Inotiv discloses FCPA probe into primate importation practices
By 
Kyle Brasseur2023-08-16T16:22:00
Inotiv disclosed the Securities and Exchange Commission (SEC) is investigating potential violations of the Foreign Corrupt Practices Act (FCPA) by the pharmaceutical testing company regarding its importation of nonhuman primates (NHPs) from Asia.
In May, the SEC requested documents and information from Inotiv and two of its subsidiaries—Envigo Global Services and Orient BioResource Center—for the period beginning Dec. 1, 2017, to present, Inotiv revealed in a regulatory filing Friday.
The company said it is cooperating with the probe.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefWashington state importer ordered to hire CCO in response to Lacey Act violations
A Washington state importer has been ordered by the Department of Justice to pay a $360,000 fine and hire a chief compliance officer after imported wood items the company claimed to be from Malaysia were found to be from China.
-
News BriefFCPA opinion tackles government-authorized payments
A new Foreign Corrupt Practices Act review by the Department of Justice offers an example of when stipends paid to foreign government personnel would not be considered a violation of the anti-bribery provisions of the law.
-
News Brief
FCPA opinion shines light on reasonable expenses for foreign officials
A Foreign Corrupt Practices Act review published by the Department of Justice offers further clarity around when the agency would determine expenses paid on behalf of a foreign official to be deemed “reasonable and bona fide.”
More from Regulatory Enforcement
-
News BriefFTC puts GM’s puts connected vehicle data practices under compliance spotlight
The U.S. Federal Trade Commission finalized its order against General Motors and its OnStar subsidiary over the improper usage of geolocation and driving behavior data of drivers.
-
ArticleKaiser plans pay $556M to settle Medicare upcoding allegations
Kaiser Health affiliates have agreed to pay more than $556 million to settle allegations originally made by whistleblowers that they ignored compliance department warnings and unlawfully reworked diagnoses for Medicare patients in order to receive higher payments from the federal government.
-
ArticleU.K. regulators move to curb AI nudification tools as scrutiny of Grok grows
The U.K. government’s spat with Big Tech owner Elon Musk over the more risque capabilities of X’s AI assistant Grok has exposed more cracks than the chatbot was ever meant to.